BioSpace News Archive

Business

Qnovia Enters Collaboration with University of Virginia to Advance Inhaled Drug Candidates for Treating Infectious Diseases

Qnovia, Inc., a pharma company developing inhaled therapeutics across a variety of indication areas, today announced it has entered into a drug development collaboration with the University of Virginia (UVA) to advance novel inhaled-drug candidates for treating bacterial infections in the lungs.

October 19, 2023
·
3 min read
Genetown

Vesigen Highlights Non-Human Primate Biodistribution of Non-Viral Technology and Functional Delivery of Genome Editors In Vivo at the Cracking the Code: The Dawn of Nucleic Acid Medicines Meeting

Vesigen Therapeutics, Inc. presented data further highlighting the potential of the Company’s non-viral ARMM technology to deliver novel therapeutic payloads to cell and tissue types relevant to multiple therapeutic areas with high unmet need.

October 19, 2023
·
3 min read
U.S. Clinical Trials Industry is Rising Rapidly USD 35.1 BN by 2030

According to Vision Research Reports, the U.S. clinical trials market size was valued at USD 23.83 billion in 2022 and is expected to surpass USD 35.1 billion by 2030 with a CAGR of 4.96% from 2022 to 2030.

October 19, 2023
·
13 min read
Pharm Country

Vyant Bio Announces Stockholder Approval of Proposed Asset Sale; 64,110 Votes Needed to Approve Plan of Dissolution; and Adjournment of Special Meeting of Stockholders

Vyant Bio, Inc. announced that its special meeting of stockholders on October 19, 2023 was reconvened resulting in the approval of the sale of all or substantially all of the assets of the Company.

October 19, 2023
·
5 min read
BioCapital

Adial Pharmaceuticals to Present at the Fall Foliage MicroCap Rodeo Conference on October 25th

Adial Pharmaceuticals, Inc. announced that it will be participating in the Fall Foliage MicroCap Rodeo Conference that will be held virtually Tuesday, October 24th through Friday, October 27th, 2023.

October 19, 2023
·
2 min read
Business

Median Technologies Reports 2023 Half-year Results and Business Indicators for the Third Quarter of 2023

Median Technologies, whose board of Directors approved the consolidated IFRS financial statements for the first half of 2023 on October 18, 2023, announces its half-year results as well as business indicators for Q3 2023.

October 19, 2023
·
9 min read
Pharm Country

Centinel Spine® Completes Divestment of its Spine Fusion Business to Silony Spine

Centinel Spine®, LLC announced that it has completed the previously announced agreement to sell its global spine fusion product portfolio and related assets to Silony Spine.

October 19, 2023
·
2 min read
Business

Cytek Biosciences to Report Third Quarter 2023 Financial Results on November 7, 2023

Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced it will report financial results for the third quarter 2023 after market close on Tuesday, November 7th, 2023.

October 19, 2023
·
2 min read
BioCapital

60 Degrees Pharma to Present Review of Safety, Efficacy Data of 8-Aminoquinolines for Malaria and Babesiosis Treatment at ILADS Annual Scientific Meeting in Boston

60 Degrees Pharmaceuticals, Inc. will present a poster titled, “Long-term safety of the tafenoquine antimalarial chemoprophylaxis regimen, a 12-month, randomized double-blind placebo-controlled trial” at the International Lyme & Associated Diseases Society annual conference in Boston on October 21, 2023.

October 19, 2023
·
9 min read
Business

Cerus Corporation to Release Third Quarter 2023 Financial Results on November 2, 2023

Cerus Corporation (Nasdaq: CERS) announced today that its third quarter 2023 financial results will be released on Thursday, November 2, 2023, after the close of the stock market.

October 19, 2023
·
1 min read